LG H&H (051900) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
28 Jan, 2026Executive summary
Q3 2024 consolidated revenue was ₩1.7136 trillion, down 1.9% year-over-year; operating profit was ₩106.1 billion, down 17.4% year-over-year.
Net income for Q3 2024 was ₩73.5 billion, a 19.4% decrease compared to the same quarter last year.
Overseas sales grew 3.5% year-over-year, now accounting for 27% of total revenue, with notable growth in China and Japan.
Nine-month cumulative revenue reached ₩5.202 trillion, down 0.7% year-over-year; operating profit was ₩415.6 billion, down 3.8%.
Cumulative net income for the nine-month period increased 3.5% year-over-year to ₩293.8 billion.
Financial highlights
Q3 2024 gross profit was ₩877.1 billion, down from ₩922.3 billion year-over-year.
Operating margin for Q3 2024 was 6.2%, down 1.2 percentage points year-over-year.
Cumulative operating margin for the nine months was 8.0%, down 0.3 percentage points year-over-year.
Total assets as of September 2024 were ₩7.6114 trillion, up ₩391.1 billion from December 2023.
Debt ratio increased to 31.2% from 30.1% at year-end 2023.
Segment performance
Beauty segment Q3 revenue fell 2.9% year-over-year to ₩650.6 billion, but operating profit rose 42.8% to ₩11.4 billion, driven by improved overseas profitability and luxury brand initiatives.
HDB segment Q3 revenue declined 1.3% year-over-year to ₩562.6 billion; operating profit dropped 11.8% to ₩41.2 billion due to increased fixed costs despite premium brand growth.
Refreshment segment Q3 revenue decreased 1.1% year-over-year to ₩500.4 billion; operating profit fell 27.5% to ₩53.5 billion amid weak domestic demand and rising input costs.
Overseas sales in China grew 12.1% year-over-year in Q3, while North America declined 15.9%; Japan sales rose 10.1%.
Latest events from LG H&H
- Operating profit and net income rose despite flat sales, driven by premium mix and China growth.051900
Q2 202428 Jan 2026 - Sharp declines in sales and profit, with FY 2026 set as a growth inflection point.051900
Q4 202528 Jan 2026 - Sales and profits fell, but overseas and premium segments showed resilience.051900
Q3 202510 Nov 2025 - Sales and profits fell in 2Q 2025, but beauty tech and Dr. Groot's US surge signal growth potential.051900
Q2 202531 Jul 2025 - Overseas growth and HDB gains offset declines in Beauty and Refreshment segments.051900
Q1 20256 Jun 2025 - Net profit rose 24.7% in FY 2024, led by overseas growth and Beauty segment gains.051900
Q4 20245 Jun 2025